Keyword: Valeant Pharmaceuticals

Chutes & Ladders: Three key Valeant execs jump ship

A trio of top execs exit embattled Valeant, Genentech promotes Bill Anderson to CEO, and Alexion replaces its CEO and CFO amid an internal Soliris sales probe. Plus more hirings, firings and retirings throughout the industry.

Manufacturing issues thwart FDA approval for Valeant eye drug

This week an FDA panel backed Valeant's skin drug brodalumab and then the regulator gave the thumbs up for an oral version of its constipation drug Relistor. But its good fortune has come to an end as the FDA has today rejected an approval for its experimental eye drug.